CytoTronics announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors today.

The Series Seed 2 round was led by new investor, LYFE Capital, and existing investor Anzu Partners. New investors including Legend Star, RIT Venture Fund (Rochester Institute of Technology), and Draper Associates also joined the round, with continued support from BoxOne Ventures and other minority financial supporters.

CytoTronics is transforming cell biology discovery with our high-throughput, semiconductor-based platforms. Their Pixel systems provide live cell insights with single-cell resolution across all cell types. By seamlessly integrating semiconductors with conventional microplates, Pixel unlocks multi-modal electrical, electrochemical, and electrophysiological capabilities, delivering an unprecedented scope of data collection and scale-up for cell biology research, drug development, and pharmaceutical manufacturing applications.